SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla's earnings have sparked intense debate, with a revenue beat overshadowed by an EPS miss, triggering volatility. The community is focused on the upcoming conference call with Elon Musk, anticipating insights on robotaxis and AI. Broader discussions revolve around Tesla's valuation and future growth prospects in the evolving EV market.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending as investors discuss the implications of the company shipping B1 samples of its QSE-5 cell and active engagements with a new top 10 major OEM. The community is focused on potential partnerships and the company's cash runway extending to 2030 following earnings. Despite some skepticism and debate around valuation, many express confidence in QuantumScape's technology and long-term potential in the battery market.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

VKTX is trending as investors discuss the recent earnings call, pipeline progress, and cash runway, with some expressing concerns about cash burn while others highlight the potential for partnerships and buyout opportunities. The community is weighing the company's prospects in the competitive GLP-1 market against its financial health and the CEO's strategy. Discussions also involve technical analysis, short positions, and potential catalysts for stock movement.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending due to its quantum computing breakthrough with HSBC, demonstrating improved bond trading predictions and reinforcing IBM's leadership in the sector; this has sparked significant community discussion around its potential impact and commercial applications with many highlighting the potential for IBM to outperform pure-play quantum stocks. Broader context includes positive sentiment around IBM's strategic focus on AI, hybrid cloud, and consulting services, as well as speculation regarding FAA contract and growing partnerships that are creating a buying opportunity.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as its community rallies around the idea of 'OG memes' making a comeback, emphasizing community building and a rejection of traditional 'coining'. The community is expressing strong conviction, with many calling for moonshot listings and celebrating its current trending status. Talk centers around the idea that while markets may be uncertain, the 'rage' will continue.

Molina Healthcare, Inc. engages in the provision of health care services. It operates through the following segments: Medicaid, Medicare, Marketplace, and Other. The company was founded by C. David Molina in 1980 and is headquartered in Long Beach, CA.

Molina Healthcare Inc

MOH is trending due to a significant earnings miss, sparking concerns about rising medical costs and the impact of Medicaid trends across the healthcare sector. Community members are discussing potential support levels and comparing MOH to competitors like CNC and UNH, while also speculating on potential catalysts like ACA subsidy extensions. The broader context involves uncertainty around government healthcare policy and its effect on managed care organizations.

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, the TRICARE program, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Centene Corp.

Centene Corp. is trending as investors react to sector-wide pressures, particularly following Molina's earnings miss, which has sparked concerns about Medicaid margins and dragged down other healthcare stocks. The community is actively debating whether the dip represents a buying opportunity ahead of Centene's upcoming earnings, with some highlighting its undervalued status and potential for a V-shaped recovery contingent upon ACA subsidy extensions and positive earnings.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group ($UNH) is trending amidst mixed sentiment following competitor earnings and broader sector concerns. Community discussions revolve around margin pressures, potential impacts from government policies, and speculation on upcoming earnings. Some traders anticipate a pre-earnings rally while others remain cautious, citing regulatory scrutiny and economic uncertainty.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is trending as investors discuss the implications of recent study results for its cystic fibrosis treatment, with community analysis focusing on the potential for higher doses to yield better outcomes. Despite some disappointment in initial lung function improvements, there's optimism around mucus reduction data and potential future catalysts like CSL royalties and lawsuit updates. The community speculates on potential buyouts and the company's overall pipeline value.

Lam Research Corp. engages in the design, manufacture, marketing, refurbishment, and provision of semiconductor processing equipment used in the fabrication of integrated circuits. It operates through the following geographical segments: United States, China, Europe, Japan, Korea, Southeast Asia and Taiwan. The company was founded by David K. Lam in 1980 and is headquartered in Fremont, CA.

Lam Research Corp.

Lam Research is trending due to positive Q3 earnings results that beat expectations, with revenue driven by AI chip production and strong systems revenue growth; however, concerns linger around the impact of tariffs and potential export restrictions, sparking mixed community sentiment regarding future guidance and market conditions; and overall, the stock's movement is influenced by broader trends in the semiconductor equipment sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mission Produce Rallies in 6 Months: Is This the Right Time to Buy?

AVO's strong fundamentals, rising avocado volumes and global expansion fuel its rally and long-term growth potential.

Here's How Procter & Gamble Looks Ahead of Q1 Earnings Release

PG's innovation and cost-saving focus drive steady organic growth, even as inflation and Greater China pressures weigh on margins.

What's in the Cards for Philip Morris Stock in Q3 Earnings Release?

PM is set for revenue and earnings growth in 3Q25, fueled by strong smoke-free momentum and solid global performance.


Why Corteva, Inc. (CTVA) is Poised to Beat Earnings Estimates Again

Corteva, Inc. (CTVA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

AVO Balances Growth & Cost Pressures: A Recipe for Long-Term Yield?

Mission Produce posts double-digit revenue growth and rising profits as disciplined cost control and global sourcing fuel its long-term yield potential.

Is Corteva (CTVA) Stock Outpacing Its Consumer Staples Peers This Year?

Here is how Corteva, Inc. (CTVA) and Local Bounti Corporation (LOCL) have performed compared to their sector so far this year.

Zacks Industry Outlook Highlights Corteva, Archer Daniels Midland, Dole and Mission Produce

Corteva, Archer Daniels Midland, Dole and Mission Produce stand out as innovation and demand trends reshape the agriculture operations industry.

4 Agriculture Operations Stocks to Watch as Trade Uncertainties Weigh

The Agriculture - Operations industry is navigating rising costs and trade pressures while tapping growth in health-focused products and innovation. CTVA, ADM, DOLE and AVO look promising.

Corteva (CTVA) stock slipped 1% in premarket trading on Friday after a Wall Street analyst downgraded the company's shares due to concerns over its proposed split.According to TheFly, KeyBanc downgraded <a href="https://stocktwits.com/symbol/CTVA">Corteva</a> stock to ‘Sector Weight’ from ‘Overweight’ without revealing a new price target. Retail sentiment on Stocktwits about the stock was still in the ‘bullish’ territory at the time of writing.<figure class="image"><img style="aspect-ratio:795/100;" src="https://news.stocktwits-cdn.com/CTVA_Oct_JPG_03e3cdb4c8.webp" alt="CTVA’s Sentiment Meter and Message Volume as of 05:26 a.m. ET on Oct. 3, 2025 | Source: Stocktwits" width="795" height="100"><figcaption>CTVA’s Sentiment Meter and Message Volume as of 05:26 a.m. ET on Oct. 3, 2025 | Source: Stocktwits</figcaption></figure>Earlier this week, Corteva announced plans to divide its operations into two standalone public companies, each focused on a distinct segment of the agriculture industry: crop protection and seed genetics. The move, approved unanimously by its board of directors, is expected to be finalized in the latter half of 2026 and is intended to be a tax-free transaction for U.S. shareholders.The brokerage reportedly struggled to see the positives arising from the breakup. In addition, KayBanc analysts noted that the management described a more challenging crop protection environment in the medium term, "which also makes us pause."Corteva has been facing intense competition from the likes of Bayer and Syngenta in its key markets, amid uncertainty over global crop demand due to uncertain tariff policies.KeyBanc noted that it would maintain its rating till receiving additional details and clarity regarding the planned spin-off transaction.The concerns of KeyBanc analysts echo the question marks raised by Citi analysts earlier this week. The brokerage downgraded the stock after noting a challenging 2026 setup for the shares, as it does not believe the separation will unlock additional shareholder value. The move brings more uncertainty amid an uncertain macro backdrop, the brokerage noted.Corteva stated that its crop protection division is expected to generate approximately $7.8 billion in net sales in 2025, accounting for around 44% of the company's total net sales. At the same time, the seeds unit’s 2025 net sales are forecasted to reach $9.9 billion, representing 56% of the company’s current sales.Corteva stock has gained 11.7% this year.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/why-is-freeport-mc-mo-ran-stock-gaining-premarket/chCuhP1R3fu">Why Is Freeport-McMoRan Stock Gaining Premarket?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

 A farmer drives agricultural machinery to spray pesticide on tomatoes in a field on May 25, 2024 in Hutubi county, Changji Hui Autonomous Prefecture, Xinjiang Uygur Autonomous Region of China. (Photo by Tao Weiming/VCG via Getty Images)

Why Is Corteva Stock Down 1% In Premarket Trading?

According to TheFly, KeyBanc downgraded Corteva stock to ‘Sector Weight’ from ‘Overweight’ without revealing a new price target.

Equity

Here's Why Corteva, Inc. (CTVA) is Poised for a Turnaround After Losing 15% in 4 Weeks

Corteva, Inc. (CTVA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Corteva, Inc. engages in the provision of seed and crop protection solutions. It focuses on the agriculture industry and food supply. It operates through the Seed and Crop Protection segments. The Seed segment is involved in the development and supply of advanced germplasm and traits that produce yield for farms. The Crop Protection segment includes the global agricultural input industry with products for weeds, insects, other pests, and diseases protection, through nitrogen management and seed-applied technologies. The company was founded in 1802 and is headquartered in Indianapolis, IN.

Current Price	$63.12
Prev Close	$61.97
Open	$61.90
Dividend Yield	1.16%
50-Day Moving Average	$68.98
Beta	0.66
Avg. Volume	4.77M
PE Ratio	30.15

52-Week High	$77.41
52-Week Low	$53.40
Market Capitalization	$42.08B
EPS (Annual)	$1.30
Price to Book	1.63
Revenue Per Employee	$768,545.45
Enterprise Value/EBITDA	N/A

CTVA
Corteva Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CTVA News

CTVACorteva Inc